Global AI Governance in Healthcare: A Cross-Jurisdictional Regulatory Analysis

Attrayee Chakraborty,Mandar Karhade
2024-06-13
Abstract:Artificial Intelligence (AI) is being adopted across the world and promises a new revolution in healthcare. While AI-enabled medical devices in North America dominate 42.3% of the global market, the use of AI-enabled medical devices in other countries is still a story waiting to be unfolded. We aim to delve deeper into global regulatory approaches towards AI use in healthcare, with a focus on how common themes are emerging globally. We compare these themes to the World Health Organization's (WHO) regulatory considerations and principles on ethical use of AI for healthcare applications. Our work seeks to take a global perspective on AI policy by analyzing 14 legal jurisdictions including countries representative of various regions in the world (North America, South America, South East Asia, Middle East, Africa, Australia, and the Asia-Pacific). Our eventual goal is to foster a global conversation on the ethical use of AI in healthcare and the regulations that will guide it. We propose solutions to promote international harmonization of AI regulations and examine the requirements for regulating generative AI, using China and Singapore as examples of countries with well-developed policies in this area.
Computers and Society,Artificial Intelligence,Machine Learning
What problem does this paper attempt to address?
The paper attempts to address the issue of global regulation of artificial intelligence (AI) in the healthcare sector. Specifically, the paper focuses on the following aspects: 1. **Comparison of global regulatory approaches**: The paper explores the regulatory approaches to AI in healthcare applications by analyzing the laws and regulations of 14 different jurisdictions, including North America, South America, Southeast Asia, the Middle East, Africa, Australia, and the Asia-Pacific region. 2. **Identification of common themes**: The paper identifies common themes in AI healthcare regulation worldwide and compares these themes with the principles for the ethical use of AI proposed by the World Health Organization (WHO). 3. **Promotion of international coordination**: The paper proposes solutions to promote international coordination of AI regulation, with a detailed discussion on the regulatory requirements for Generative AI (GenAI), using China and Singapore as examples. 4. **Global dialogue on the ethical use of AI**: The ultimate goal of the paper is to promote a global dialogue on the ethical use of AI in healthcare and to propose a corresponding regulatory framework to ensure the safe, effective, and fair use of AI technology. Overall, the paper aims to provide guidance and recommendations for the ethical use and regulation of AI in the healthcare sector through a global perspective analysis.